Assessment of PD-L1 expression on circulating tumor cells (CTCs) and immune cells in peripheral blood of patients with small cell lung cancer (SCLC)

被引：1
|
作者：
Papadaki, M. A. [1 ]
Kapetanaki, E-E. [1 ]
Vorrias, E. [2 ]
Mavroudis, D. [3 ]
Agelaki, S. [3 ]
机构：
[1] UOC Univ Crete, Lab Translat Oncol, Sch Med, Iraklion, Greece
[2] Univ Gen Hosp Herakl, Dept Med Oncol, Iraklion, Greece
[3] Univ Crete, Univ Gen Hosp Heraklion, Sch Med, Dept Med Oncol,Lab Translat Oncol, Iraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.237
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1653P
引用
收藏
页码：S1166 / S1166
页数：1
相关论文
共 50 条
  • [41] Monitoring PD-L1 expression on circulating tumor cells (CTCs) in patients with NSCLC treated with PD1 inhibitors.
    Guibert, Nicolas Marie
    Delaunay, Myriam
    Lusque, Amellie
    Gouin, Sandrine
    Boubekeur, Nadia
    Rouquette, Isabelle
    Clermont, Estelle
    Fourtoul, Aurelien
    Favre, Gilles
    Pradines, Anne
    Mazieres, Julien
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [42] Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells from Patients with Non-Small-Cell Lung Cancer
    Cheng, Yuxin
    Wang, Ting
    Lv, Xin
    Li, Rutian
    Yuan, Ling
    Shen, Jie
    Li, Yan
    Yan, Tingting
    Liu, Baorui
    Wang, Lifeng
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2069 - 2078
  • [43] Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells From Patients With Non-Small-Cell Lung Cancer
    Cheng, Y.
    Wang, T.
    Li, R.
    Lv, X.
    Yuan, L.
    Shen, J.
    Li, Y.
    Yan, T.
    Liu, B.
    Wang, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S415 - S416
  • [44] Characterization of tumor cells and assessment of PD-L1 expression in pleural effusions of metastatic non-small cell lung cancer patients
    Thompson, Jeffrey C.
    Savitch, Samantha L.
    Fan, Ryan
    Yee, Stephanie S.
    Powers, Christian A.
    Yu, Gordon
    Gebrian, Lauren
    Rao, Chandra
    Gross, Steve
    Feldman, Michael
    Vachani, Anil
    Carpenter, Erica L.
    [J]. CANCER RESEARCH, 2017, 77
  • [45] Morphologic assessment of peripheral blood smears in patients with circulating tumor cells (CTCs)
    Bethel, K.
    Scuderi, R.
    Marrinucci, D.
    Fisher, J. M.
    Lazarus, N.
    Lazar, D.
    Kuhn, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Sequential Assessment of DNA Damage Response and PD-L1 Expression in Circulating Tumor Cells of Lung Cancer Patients during Radiotherapy
    Lin, Steven H.
    He, Jianzhong
    Edelman, Martin
    Xu, Ting
    Gao, Hui
    Reuben, James
    Qiao, Yawei
    Liu, Holly
    Amstutz, Pete
    Hahn, Stephen
    Komaki, Ritsuko U.
    Liao, Zhongxing
    Tang, Cha-Mei
    Adams, Daniel
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S266 - S267
  • [47] Investigating the correlation between circulating tumor cell (CTC) detection and immune checkpoint expression in the peripheral blood of patients with small cell lung cancer (SCLC)
    Agelaki, S.
    Boumpouli, A.
    Nikolarakou, N.
    Vorrias, E.
    Michaelidou, K.
    Mala, A.
    Kyriakidou, A. C.
    Mavroudis, D.
    Papadaki, M. A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S131 - S132
  • [48] Simultaneous characterization of rare immune cell subpopulations and PD-L1 expressing CTCs in peripheral blood of cancer patients
    Jendrisak, Adam
    Rodriguez, Angel
    Byun, Jiyun
    Graf, Ryon
    Wang, Yipeng
    Landers, Mark
    Dittamore, Ryan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [49] Simultaneous characterization and quantification of immune cell subpopulations and PD-L1 expressing CTCs in peripheral blood of cancer patients
    Krupa, Rachel
    Lu, David
    Jendrisak, Adam
    Rodriguez, Angel
    Ebrahim, Nadia
    Richardson, Robin
    Nisperos, Sean
    Graf, Ryon
    Byun, Jiyun
    Wang, Yipeng
    Landers, Mark
    Dittamore, Ryan
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [50] Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment
    Messaritakis, Ippokratis
    Nikolaou, Michail
    Politaki, Eleni
    Koinis, Fillipos
    Lagoudaki, Eleni
    Koutsopoulos, Anastasios
    Georgoulia, Nefeli
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    [J]. LUNG CANCER, 2018, 124 : 270 - 278
12345